BASEC ID | Project title | Type of project | Type of clinical trial | Study phase (clinical trials only) | multi- / monocentric | Category | Principal investigator | Sponsor | Investigational sites | Lead EC | Local EC(s) | Approval date | Minors | Study Ended | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2015-00010 | Cytokine Clearance with Cytoabsorbant Device during Cardiac Bypass: a Pilot Study | clinical trial | medical devices | monocentric | A | Dr Antoine Schneider | CHUV |
CHUV, Lausanne |
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) | 12.04.2016 | Study has ended | ||||
2015-00011 | Diagnostic performance of an automated breast ultrasound system (ABUS): a single centre study | clinical trial | medical devices | monocentric | A | PD Dr. med. Dr. sc. hum. Andreas Boss | Institut für Interventionelle und diagnostische Radiologie USZ |
Institut für Interventionelle und diagnostische Radiologie USZ , Zürich |
Kantonale Ethikkommission Zürich | 12.01.2016 | |||||
2015-00012 | Mixed methods study to test the efficacy of the adapted German PRO-SELF© Plus Pain Control Program, an intervention directed at outpatients with cancer and their family caregivers to reduce pain and r More ... | clinical trial | other clinical trials | multicentric | A | PD Dr. Elisabeth Spichiger | University Basel, Medical Faculty, Institute of Nursing Science |
University Basel, Medical Faculty, Institute of Nursing Science, Basel Inselspital Bern, University Hospital, Department of Nursing/MTT, Bern University Hospital Zurich, Center Clinical Nursing Scienc More ... |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich | 29.03.2016 | Study has ended | |||
2015-00015 | Endocrine and emotional effects of lisdexamfetamine and d-amphetamine: a placebo-controlled study in healthy subjects (LisDexStudy) | clinical trial | drugs | phase 1 | monocentric | C | Prof. Dr. med. Matthias Liechti | University Hospital Basel |
University Hospital Basel, Basel |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 23.12.2015 | Study has ended | |||
2015-00020 | SINGLE CENTER, OPEN-LABEL, PROSPECTIVE STUDY TO CHARACTERIZE THE PHARMACOKINETICS OF METAMIZOLE AND ITS METABOLITES FOLLOWING INTRAVENOUS ADMINISTRATION IN CHILDREN LESS THAN 6 YEARS OLD | clinical trial | drugs | phase 2 | monocentric | B | Prof. Marc Pfister | University of Basel Children s Hospital |
University of Basel Childrens Hospital, Basel |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 05.01.2016 | yes | Study has ended | ||
2015-00023 | GS-US-326-1100: A Combined Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluating the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severel More ... | clinical trial | drugs | phase 2 | multicentric | C | Prof. Dr Gerhard Rogler | Gilead Sciences |
USZ, Zürich Gastroenterologische Praxis Balsiger, Seibold & Partner, Bern USB Gastroenterologie und Hepathologie , Basel |
Kantonale Ethikkommission Zürich | Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Bern | 18.03.2016 | Study has ended | ||
2015-00024 | Effects of empagliflozin an SGLT2-inhibitor on healthy volunteers with induced hypotonic hyponatremia - the DIVE-study | clinical trial | drugs | n/a | monocentric | C | Prof / Mirjam / Christ | Endokrinologie, Universitätsspital Basel |
Endocrinology , Basel |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | 08.01.2016 | Study has ended | |||
2015-00031 | Double-blind, randomized, placebo-controlled, phase III study on the efficacy and tolerability of a 48-week treatment with two different doses of budesonide effervescent tablets vs. placebo for mainte More ... | clinical trial | drugs | phase 3 | multicentric | C | Dr. med. Alain Schoepfer | Dr. Falk Pharma GmbH |
University Hospital Lausanne/CHUV Division of Gastroenterology and Hepatology, Lausanne Praxis für Gastroenterologie, Römerstraße 7, CH-4600 Olten Universitätsklinik Basel Abteilung für Gastroenterolo More ... |
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) | Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Zürich | 25.05.2016 | Study has ended | ||
2015-00032 |
The effect of biopolymer based lipid emulsions on GI function, GI peptide response and satiation in healthy volunteers; a randomized, double blind, unbalanced threeway crossover study. |
clinical trial | other clinical trials | monocentric | B | Dr. Andreas Setingoetter | University Hospital Zurich |
University Hospital Zurich, Zurich |
Kantonale Ethikkommission Zürich | 01.04.2016 | Study has ended | ||||
2015-00033 | A Phase I/II, multicenter, open-label, dose-escalation study of the safety and pharmacokinetics of cobimetinib in pediatric and young adult patients with previously treated solid tumors | clinical trial | drugs | phase 1 | monocentric | C | Dr. Nicolas Gerber | F. Hoffmann-La Roche Ltd. |
Universitäts-Kinderspital, Zürich |
Kantonale Ethikkommission Zürich | 15.07.2016 | yes | Study has ended | ||
2015-00034 | Prevalence of HPV infection using self-sampling screening and monitoring the Earlier Impact of HPV-Vaccination Program in Switzerland | clinical trial | medical devices | monocentric | A | Prof Patrick Petignat | Geneva university hospital |
Hopital universitaire de Geneve, geneva |
Commission Cantonale d'éthique de la recherche Genève (CCER) | 05.01.2016 | Study has ended | ||||
2015-00039 | BIOTRONIK – Safety and clinical performance of the self-expanding transcatheter BIOVALVE prosthesis in subjects with severe symptomatic calcified aortic valve stenosis suitable for transfemoral transc More ... | clinical trial | medical devices | monocentric | C2 | Prof. Robert Bauernschmitt | BIOTRONIK AG - Clinical Affairs |
UniversitätsSpital Zürich - Klinik für Herz- und Gefässchirurgie, Zürich |
Kantonale Ethikkommission Zürich | 08.03.2016 | Study has ended | ||||
2015-00040 |
A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis |
clinical trial | drugs | phase 3 | multicentric | C | Prof. Dr. Annalisa Berzigotti | Intercept Pharmaceuticals Inc. |
University Clinic of Visceral Surgery and Medicine, Bern Kantonsspital St. Gallen, St. Gallen EPATOCENTRO TICINO, Lugano USZ, University of Zurich, Zürich |
Kantonale Ethikkommission Bern | Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Zürich, Comitato etico cantonale Ticino | 01.06.2016 | Study has ended | ||
2015-00042 |
SAKK 16/14 Anti-PD-L1 antibody MEDI4736 in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC). A multicenter single-arm phase II trial. |
clinical trial | drugs | phase 2 | multicentric | C | Dr. med. David König | SAKK |
Universitätsspital Basel, Basel Inselspital Bern, Bern Spital STS AG Thun, Thun Kantonspital Aarau, Aarau Kantonsspital Baden, Baden Luzerner Kantonsspital, Luzern St. Claraspital, Basel Hôpitaux Univ More ... |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | Ethikkommission Nordwest- und Zentralschweiz EKNZ, Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Commission cantonale d'Éthique de la Recherche s More ... | 30.03.2016 | |||
2015-00043 | M13-545: A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 Once Daily Monotherapy to Methotrexate (MTX) Monotherapy in MTX-Naïve Subjects with Moderately to Severely Active Rheumatoid Arthri More ... | clinical trial | drugs | phase 3 | monocentric | C | Prof. Dr. Jean Dudler | AbbVie AG |
Service de rhumatologie HFR Fribourg – Hôpital Cantonal, Fribourg |
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) | 14.03.2016 | Study has ended | |||
2015-00044 | M13-549: A Phase III, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Are on a Stable Dose of Conventional Synthetic More ... | clinical trial | drugs | phase 3 | multicentric | C | Prof. Dr. Jean Dudler | AbbVie AG |
HFR Kantonsspital Freiburg, Rheumatologie, 1708 Freiburg Kantonsspital Aarau, Abteilung Rheumatologie, Aarau |
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) | Ethikkommission Nordwest- und Zentralschweiz EKNZ | 23.02.2016 | Study has ended | ||
2015-00055 | Assessment of psychological and metabolic responses during fructose intolerance breath tests in patients with functional GI disorders: placebo-controlled breath testing | clinical trial | other clinical trials | monocentric | A | Dr. med Clive Wilder-Smith | Brain-Gut Research Group/Gastroenterology Group Practice |
Brain-Gut-Research Group/Gastroenterology Group Practice, Bern |
Kantonale Ethikkommission Bern | 17.05.2016 | Study has ended | ||||
2015-00057 |
GA29144 - A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ETROLIZUMAB AS AN INDUCTION AND MAINTENANCE TREATMENT FOR PATIENTS WITH M More ... |
clinical trial | drugs | phase 3 | multicentric | C | Prof. Dr. Stephan Brand | F. Hoffmann-La Roche Ltd. |
Kantonsspital St. Gallen, St. Gallen Inselspital Bern, Bern Crohn-Colitis Zentrum Bern, Bern Universitätsspital Zürich, Zürich |
Ethikkommission Ostschweiz (EKOS) | Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich | 15.03.2016 | Study has ended | ||
2015-00059 | Sienna+® Injection Time Pilot Study: A prospective observational multicentre, controlled clinical trial to evaluate the performance of superparamagnetic iron oxide vs. standard technique as tracer in More ... | clinical trial | medical devices | multicentric | A | PD Dr. Cornelia Leo | Kantonsspital Baden AG, Frauenklinik |
Kantonsspital Baden AG, Baden Universitätsklinik für Frauenheilkunde, Inselspital, Bern |
Ethikkommission Nordwest- und Zentralschweiz EKNZ | Kantonale Ethikkommission Bern | 05.10.2016 | ||||
2015-00068 | Responsiveness of the German Version of the Neck Disability Index (NDI-G) | clinical trial | other clinical trials | monocentric | A | Dr. Jaap Swaneburg | Balgrist University Clinic |
Balgrist University Clinic, Zurich |
Kantonale Ethikkommission Zürich | 28.01.2016 | Study has ended | ||||